2. UroToday Home
  3. Recent Abstracts
  4. Urologic Oncology
  5. Prostate Cancer

GU Cancers Symposium 2013 - Updated interim analysis (55% OS) of COU-AA-302, a randomized phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy - Slide Lecture

ORLANDO, FL, USA (UroToday.com) - Presented by Charles J. Ryan, MD, et al. at the 2013 Genitourinary Cancers Symposium - February 14 - 16, 2013 - Rosen Shingle Creek - Orlando, Florida USA

 


gucancerssympalt

 

View Full 2013 GU Cancers Symposium Coverage